Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-11-17
1990-06-05
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3141
Patent
active
049314599
ABSTRACT:
Novel benzothiophenes having antiallergic activity and both novel and other selected benzothiophenes having activity for treating acute respiratory distress syndrome. The benzothiophenes of the present invention are particularly 2-tetrazolylcarboxamides of the benzothiophenes.
REFERENCES:
patent: 3452039 (1969-06-01), Buchanan et al.
patent: 4287125 (1981-09-01), Soula
patent: 4408075 (1983-10-01), Soula et al.
J. Org. Chem., 1985, 3717-3721; Gerard Soula; "Tris (polyoxaalkyl)amines (Trident), A New Class of Solid Liquid Phase-Transfer Catalysts".
Aldrich Chemical Co. Catalog; TDA-1, "Solid-Liquid Phase-Transfer Catalyst".
Connor David T.
Mullican Michael D.
Sorenson Roderick J.
Thueson David O.
Springer David B.
Thierstein Joan
Warner-Lambert & Company
LandOfFree
Method for treating acute respirator distress syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating acute respirator distress syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating acute respirator distress syndrome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-491805